CeriBell, Inc. (CBLL) vs iRadimed Corporation (IRMD)
CeriBell, Inc. and iRadimed Corporation are both Medical Devices companies. iRadimed Corporation is the larger, with a market value of $1.1B against $914.2M — 1.2× the size. CeriBell, Inc. has negative trailing earnings, so its P/E is not meaningful; iRadimed Corporation trades at 47.1×. CeriBell, Inc. grew revenue faster over the last twelve months: 31.7% against 11.2%. iRadimed Corporation has the higher net margin (26.7% vs −64.7%) and the higher return on invested capital (40.4% vs −229.8%). Across the 17 metrics below, iRadimed Corporation leads on 11 and CeriBell, Inc. on 6.
Valuation
Profitability
| Metric | CBLL | IRMD | Medical Devices median |
|---|---|---|---|
| Gross margin | 88.90% | 75.86% | 56.01% |
| Operating margin | (68.62%) | 31.92% | (15.03%) |
| Net margin | (64.73%) | 26.70% | (20.40%) |
| Free cash flow margin | (55.02%) | 28.43% | (7.24%) |
| Return on equity | (43.93%) | 23.52% | (15.32%) |
| Return on assets | (35.29%) | 20.82% | (19.72%) |
| Return on invested capital | (229.76%) | 40.36% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack